Molecular Triaging of Newly Diagnosed Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Fluorouracil|DRUG: Doxorubicin|DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Bevacizumab
Sponsor: M.D. Anderson Cancer Center